Showing posts with label conference. Show all posts
Showing posts with label conference. Show all posts

Tuesday, July 9, 2013

Johns Hopkins Pituitary Patient Day 2013

Johns Hopkins Pituitary Patient Day

Join us on Saturday, September 28, 2013, for the 5th Annual Patient Education Day at the Johns Hopkins Pituitary Center.

When: Saturday, September 28, 2013
Time: 9:30 a.m.
Location:
Johns Hopkins Mt. Washington Conference Center
5801 Smith Avenue
Baltimore, MD 21209
map and directions
Location of the pituitary gland in the human brain
Location of the pituitary gland in the human brain (Photo credit: Wikipedia)
Patient Education Day Agenda:
9:30 – 10:00 AMREGISTRATION
10:00 – 10:25 AMWhat is the pituitary gland, where it is located, what it does, and what can go wrongGary Wand, MD
10:30 – 10:50 AMHow pituitary tumors can affect your visionPrem Subramanian, MD, PhD
Vivek Patel, MD, PhD
10:50 – 11:10 AMCushing disease journey: a patient’s perspectiveStacey Hardy
11:15 – 11:40 AMSurgery for Pituitary tumors: from very tiny to very largeAlfredo Quinones-Hinojosa, MD
Gary Gallia, MD, PhD
Alessandro Olivi, MD
11:40 – 12:00 PMRadiation therapy: when, why, and howLawrence Kleinberg, MD
Kristen Redmond, MD
12:05 – 12:25 PMThe medications you may be taking (new and old ones): what you need to knowRoberto Salvatori, MD
12:30 – 1:25 PMLunch
1:30 – 3:00 PMPM Round table sessions:
1) Medical therapy (Wand/Salvatori)
2) Surgical therapy (Quinones/Gallia/Olivi)
3) Radiation therapy (Redmond/Kleinberg/Lim)
4) Vision issues (Subramanian/Patel)
*This schedule is subject to change
Please R.S.V.P. by September 13, 2013, vie email (preferred) to PituitaryDay@jhmi.edu  or to Alison Dimick at 410-955-3921.
Reservations will be taken on a first-come, first-serve basis.

Friday, June 21, 2013

Want to Go to an Endocrinology Conference?

73rd Scientific Sessions (2013) of American Diabetes Association CME
June 21-25, 2013 -Chicago, Illinois, United States
6th International Conference on Children s Bone Health CME
June 22-25, 2013 -Rotterdam, Netherlands
2013 Annual Meeting of the Society for Behavioral Neuroendocrinology CME
June 23-26, 2013 -Atlanta, Georgia, United States
17th Annual Conference on Hypertension - Focus on Hypertension, Diabetes and Dyslipidemia CME
June 28-30, 2013 -Charleston, South Carolina, United States
Bone Densitometry Comprehensive Exam Review CME
August 3, 2013 -Houston, Texas, United States
4th World Congress on Diabetes & Metabolism CME
August 14-16, 2013 -Skokie, Illinois, United States
Anti-Aging Medicine: Advances in Hormone Replacement CME
August 17-18, 2013 -Chicago, Illinois, United States
World Congress on Endocrinology 2013 CME
August 26-28, 2013 -Raleigh, North Carolina, United States
HBPR 2013: High Blood Pressure Research 2013 Scientific Sessions CME
September 11-14, 2013 -New Orleans, Louisiana, United States
35th Annual British Andrology Society Meeting CME
September 13-14, 2013 -Liverpool, United Kingdom
5th Florence-Utah Symposium on Genetics of Male Infertility
September 19-21, 2013 -Florence, Italy
2013 Cardiometabolic Health Congress CME
October 2-5, 2013 -Boston, Massachusetts, United States
Bone Densitometry: Principles and Procedures CME
October 5-6, 2013 -Houston, Texas, United States
11th Annual Meeting of Androgen Excess & PCOS Society CME
October 17-18, 2013 -Newport, Rhode Island, United States
AAES 2014 Annual Meeting CME
April 27-29, 2014 -Boston, Massachusetts, United States
74th Scientific Sessions of American Diabetes Association CME
June 13-17, 2014 -San Francisco, California, United States
50th EASD Annual Meeting CME
September 15-19, 2014 -Vienna, Austria
84th Annual Meeting of the American Thyroid Association CME
October 29 - November 2, 2014 -Coronado, California, United States
ENDO 2015 CME
March 5-8, 2015 -San Diego, California, United States
AAES 2015 Annual Meeting CME
May 17-19, 2015 -Nashville, Tennessee, United States

Thursday, November 29, 2012

Magic Foundation Cushing's Conference, 2013

Dates:

Friday, April 19, 2013 - Registration and exhibits-4 PM to 9 PM

Saturday, April 20, 2013 - Educational segments

Sunday, April 21, 2013 – Educational Segments

Monday, April 22, 2013 – Departure or visiting sites of Las Vegas

 

Registration: $155 for members $190 for non-members (includes 1 yr membership)

Registration fee includes: Thursday exhibits and refreshments, Friday continental breakfast, and lunch and Saturday continental breakfast and lunch. An optional dinner will be held on Friday night for $25.00 per person.

For additional attendees in your family there will be no registration fee but a $75 charge for inclusion of the segments and meals. (optional dinner on Friday night not included in the $75 fee)

 

Accommodations:

Tuscany Suites & Casino (Just off the Las Vegas Strip)

255 East Flamingo Rd

Las Vegas, NV

Guest room costs: 

Friday and Saturday $105 per guestroom, single or double occupancy ($117.60 w/tax)

Sunday thru Thursday $65 per guestroom, single or double occupancy ($72.80 w/tax)

Reservations made after March 20, 2013 at noon will be charged the prevailing room rate if accommodations are available. To book your room you must call Tuscany Room Reservations, 877-887-2261 and ask for MAGIC Foundation group rates. You will be required to provide a major credit card for the first night’s room and tax deposit, which will be charged in order to guarantee accommodations.

Friday, April 20, 2012

Magic Foundation Cushing's Conference

 

Includes: Adult Growth Hormone Deficiency, Panhypopituitarism, Cushings and Acromegaly

July 19-22, 2012

Westin- Lombard

Chicago, Illinois

 For immediate information please email or call our office: ContactUs@magicfoundation.org or (708) 383-0808.)

Speakers include:

 

 

 

More information (PDF)

Register Online

Monday, April 9, 2012

Day Nine, Cushing's Awareness Challenge

UVA 2004
Cushing's Conventions have always been special times for me - we learn a lot, get to meet other Cushies, even get referrals to endos!

As early as 2001 (or before) my pituitary function was dropping.  My former endo tested annually but did nothing to help me with the symptoms.

In the fall of 2002 my endo refused to discuss my fatigue or anything at all with me until I lost 10 pounds. He said I wasn't worth treating in my overweight condition and that I was setting myself up for a heart attack. He gave me 3 months to lose this weight. Those 3 months included Thanksgiving, Christmas and New Years.  Needless to say, I left his office in tears, again.

Fast forward 2 years to 2004.  I had tried for awhile to get my records from this endo. He wouldn't send them, even at doctors' or my requests.

I wanted to go see Dr. Vance at UVa but I had no records so she would't see me until I could get them.

Finally, my husband went to the former endo's office and threatened him with a court order, The office manager managed to come up with about 13 pages of records. For going to him from 1986 to 2001 including weeks and weeks at NIH and pituitary surgery, that didn't seem like enough records to me.

In April of 2004, many of us from the message boards went to the UVa Pituitary Days Convention. That's where the picture above comes in.  Other pictures from that convention are here.

By chance, we met a wonderful woman named Barbara Craven. She sat at our table for lunch on the last day and, after we learned that she was a dietitian who had had Cushing's, one of us jokingly asked her if she'd do a guest chat for us. I didn't follow through on this until she emailed me later. In the email, she asked how I was doing. Usually I say "fine" or "ok" but for some reason, I told her exactly how awful I was feeling.

Barbara emailed me back and said I should see a doctor at Johns Hopkins. I said I didn't think I could get a recommendation to there, so SHE referred me. The doctor got right back to me, set up an appointment. Between his vacation and mine, that first appointment turned out to be Tuesday, Sept 14, 2004.

Just getting through the maze at Johns Hopkins was amazing. They have the whole system down to a science, moving from one place to another to sign in, then go here, then window 6, then... But it was very efficient.

My new doctor was wonderful. Understanding, knowledgeable. He never once said that I was "too fat" or "depressed" or that all this was my own fault. I feel so validated, finally.

He looked through my records, especially at my 2 previous Insulin Tolerance Tests. From those, he determined that my growth hormone has been low since at least August 2001 and I've been adrenal insufficient since at least Fall, 1999 - possibly as much as 10 years! I was amazed to hear all this, and astounded that my former endo not only didn't tell me any of this, he did nothing. He had known both of these things - they were in the past records that I took with me. Perhaps that was why he had been so reluctant to share copies of those records. He had given me Cortef in the fall of 1999 to take just in case I had "stress" and that was it.

The new endo took a lot of blood (no urine!) for cortisol and thyroid stuff. I went back on Sept. 28, 2004 for arginine, cortrosyn and IGF testing.

He said that I would end up on daily cortisone - a "sprinkling" - and some form of GH, based on the testing the 28th.

For those who are interested, my new endo is Roberto Salvatori, M.D.
Assistant Professor of Medicine at Johns Hopkins

Medical School: Catholic University School of Medicine, Rome, Italy
Residency: Montefiore Medical Center
Fellowship: Cornell University, Johns Hopkins University
Board Certification: Endocrinology and Metabolism, Internal Medicine

Clinical Interests: Neuroendocrinology, pituitary disorders, adrenal disorders

Research Interests: Control of growth hormone secretion, genetic causes of growth hormone deficiency, consequences of growth hormone deficiency.

Although I have this wonderful doctor, a specialist in growth hormone deficiency at Johns Hopkins, in November, 2004, my insurance company saw fit to over-ride his opinions and his test results based on my past pharmaceutical history! Hello??? How could I have a history of taking GH when I've never taken it before?

Of course, I found out late on a Friday afternoon. By then it was too late to call my case worker at the drug company, so we had to appeal on Monday. My local insurance person also worked on an appeal, but the whole thing was  just another long ordeal of finding paperwork, calling people, FedExing stuff, too much work when I just wanted to start feeling better by Thanksgiving.

As it turned out the insurance company rejected the brand of hGH that was prescribed for me. They gave me the ok for a growth hormone was just FDA-approved for adults on 11/4/04. The day this medication was approved for adults was the day after my insurance said that's what is preferred for me. In the past, this form of hGH was only approved for children with height issues. Was I going to be a ginuea pig again?

The new GH company assigned a rep for me, submitted info to pharmacy, and waited for insurance approval, again.

I finally started the Growth Hormone December 7, 2004.

Was the hassle and 3 year wait worth it?

Stay tuned for Day 12, April 12, 2012 when all will be revealed.

 

Read Dr. Barbara Craven's Guest Chat, October 27, 2004

Thanks for reading :)

 

MaryO

 

Saturday, December 31, 2011

FDA Rare Disease Patient Advocacy Day

On March 01, 2012, the Food and Drug Administration (FDA) will celebrate the fifth annual Rare Disease Day by hosting a "FDA Rare Disease Patient Advocacy Day" to engage and educate the rare disease community on regulatory processes related to rare diseases.

 

This meeting is intended to enhance the awareness of the rare disease community as to FDA’s roles and responsibilities in the development of products (drugs, biological products and devices) for the diagnosis, prevention, and/or treatment of rare diseases or conditions. 

 

This educational meeting will consist of live and interactive simultaneous webcast of presentations provided by FDA experts from various Centers and Offices, as well as from outside experts. The interactive meeting will include two general panel discussion sessions, as well as afternoon breakout sessions for more in-depth information on the roles of FDA. In addition, on-site attendees will have an opportunity during lunch to engage with FDA and outside experts in a small group setting.

Registration:

While attendance is free, registration is required to attend the event.

Register for FDA Rare Disease Patient Advocacy Day disclaimer icon

If you need sign language interpretation during this meeting, please contact Megan McNamee at mmcnamee@icfi.com by February 15, 2012.FDA Rare Disease Patient Advocacy Day logo

Location and Directions:

White Oak Campus
10903 New Hampshire Ave
Silver Spring, MD, 20993

Location, directions, and other information about White Oak

Date:

March 01, 2012

Agenda:

Event agenda is in preparation and will be posted prior to the meeting

Webcast:

To connect to the live webcast of the meeting please follow the Connect Pro instructions.

 

Sponsors:

The FDA Rare Disease Patient Advocacy Day is supported by the Food and Drug Administration (FDA), the National Institutes of Health (NIH), the National Organization for Rare Disorders (NORD), and the Genetic Alliance.

NIH 2012  Rare Disease Day logoThe FDA encourages all attendees to also plan on attending the National Institutes of Health (NIH) Rare Disease Day day-long celebration on February 29, 2012.

 

Rare Disease Day at NIH



Rare Disease Day at NIH (RDD@NIH)

On February 29, 2012, the National Institutes of Health (NIH) will celebrate the fifth annual Rare Disease Day with a day-long celebration and recognition of the various rare diseases research activities supported by the NIH Office of Rare Diseases Research, the NIH Clinical Center, other NIH Institutes and Centers; the Food and Drug Administration’s Office of Orphan Product Development; the National Organization for Rare Disorders; and the Genetic Alliance. Rare Disease Day at NIH (RDD@NIH) will be held in the Clinical Center’s Masur Auditorium (Building 10) from 8:30 a.m. to 5:00 p.m. Attendance is free and open to the public.

In addition to the various scheduled talks, we expect to have posters and exhibits from many groups relevant to the rare diseases research community. In association with the Global Genes Project, we again encourage all attendees to wear their favorite pair of jeans.

While attendance is free, we would like to know how many people are planning to attend to prepare accordingly. If you would like to display a poster or exhibit, please include that information on your registration form. You can contact Dr. David J. Eckstein at eckstein@od.nih.gov for more information.

The NIH Office of Rare Diseases Research encourages all attendees to also plan on attending the Food and Drug Administration’s Rare Disease Day activities on March 1, 2012.
Visit the NIH Visitors and Security website for the latest instructions and updates. Please allow 30 minutes to move through security.

Sign language interpreters will be provided. Individuals with disabilities who need reasonable accommodation to participate in this event should contact Kimberly Potter at kpotter@icfi.com or 301-251-4962.

About Rare Disease Day
Rare Disease Day was established to raise awareness with the public about rare diseases, the challenges encountered by those affected, the importance of research to develop diagnostics and treatments, and the impact of these diseases on patients' lives. The focus of Rare Disease Day 2010 was 'Patients and Researchers, Partners for Life!' and is aligned with ORDR's philosophy that researchers need to work closely with patients and patient advocacy groups to maximize chances for success. This philosophy has been put into practice in our very successful Rare Diseases Clinical Research Network.

There are about 7000 rare diseases identified in the United States. About 80 percent of rare diseases are genetic in origin and it is estimated that about half of all rare diseases affect children. Rare diseases can be chronic, progressive, debilitating, disabling, severe and life-threatening. Information is often scarce and research is usually insufficient. People affected face challenges such as delays in obtaining a diagnosis, misdiagnosis, psychological burden and lack of support services for the patient and family. The goals remain for rare disease patients to obtain the highest attainable standard of health and to be provided the resources required to overcome common obstacles in their lives.
By highlighting these issues, the NIH Office of Rare Diseases Research hopes to
  • Raise awareness of rare diseases
  • Strengthen the voice of patients and patient advocacy groups
  • Give hope and information to patients
  • Bring stakeholders closer together
  • Coordinate policy actions within the United States and with other countries
  • Inspire continued growth of the awareness of rare diseases
  • Emphasize rare disease research and the search for new therapeutics
  • Get equality in access to care and treatment

The first Rare Disease Day sponsored by EURORDIS was held in Europe on February 29, 2008. February 29th was chosen since it is a rare day and it is symbolic of rare diseases. 2009 was the first time that Rare Disease Day was observed in the U.S. In addition to 17 European countries participating in Rare Disease Day 2009, the United States was joined by Argentina, Australia, Canada, China, Colombia, and Taiwan in celebrating the first global Rare Disease Day. The National Organization for Rare Disorders serves as the coordinator of this activity in the United States.

The Global Genes Project

The Global Genes ProjectA video developed by a rare disease parent advocate circulated on YouTube as part of World Rare Disease Day 2009, making a connection between jeans and genes. This video inspired a group of individuals and rare disease organizations to take this connection to the next level by creating the Global Genes Project, a grassroots effort to use jeans to raise awareness for rare genetic disorders.<


This group has grown and continues to add individuals and organizations that want to be involved. The hope is that the rare disease community as a whole will view this initiative as an opportunity to build unity around this important cause. The goal is to create a platform for collaboration, while building awareness about the prevalence of rare diseases, educating the public about genes and the impact they play in rare diseases, and engaging support from the general public.

There are numerous organizations that are working to help some of the individual diseases. They are funding much needed research, helping drive policy and develop educational programs, all in an effort to bring hope to this underserved community. The Global Genes Project encourages those who are concerned and compelled to join the cause to help both individual rare disease organizations, children and their families affected, as well as the community as a whole.

More information: http://rarediseases.info.nih.gov/RareDiseaseDay.aspx

Monday, September 19, 2011

2nd California Pituitary Hormonal Health Symposium, October 22, 2011

Sharmyn McGraw writes:

Hey Everyone!!! I’d like to invite all of you to help me spread the word about our Hormonal & Pituitary Health Symposium Oct. 22, 2011, Santa Monica CA. It’s free and a continental breakfast and box lunch is included and the best part is hearing from our team of neuroendocrine experts and meeting many new friends. To register and for a copy of the events schedule www.brain-tumor.org or call Pat Fitzwater at (805) 300-9154 I hope to see many of you there!

Peace and great health all!

Sharmyn

Learn about your Master Gland

This symposium aims to educate patients, their families and the public about the importance of the "Master Gland" in health and in illness. 

Topics covered will include: the basics of pituitary gland function and malfunction; signs, symptoms and treatment of hormonal excess and hormonal deficiency; epidemiology of pituitary adenomas and related brain tumors; treatment options for pituitary tumors (acromegaly, Cushing's  disease, prolactinoma and non-functional adenomas, craniopharyngioma) including endonasal endoscopic surgery, radiotherapy and non-surgical therapies.

Additional topics will include optimizing your access to care, insurance issues and finding the appropriate pituitary specialists, as well as information about clinical trials in pituitary hormonal disorders

More information and registration